C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
11/2011
11/30/2011	CN102264730A 用于生产生育三烯酚及衍生物的方法 Tocotrienol and derivatives production method for
11/30/2011	CN102260251A 一种大环内酯类化合物及其制备和应用 A macrolide compounds and their preparation and use
11/29/2011	CA2494302C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
11/29/2011	CA2438524C Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
11/24/2011	WO2011146401A1 Novel inhibitors of hepatitis c virus replication
11/24/2011	US20110288314 Phloroglucinol derivatives from ecklonia cava having anti-hiv-1 inhibitory activity
11/23/2011	EP2388255A1 Polysubstituted benzofurans and medicinal applications thereof
11/23/2011	EP2387569A1 Novel herbicides
11/23/2011	CN102256963A Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
11/23/2011	CN102256962A And pyrazole derivatives for use as plant growth regulators
11/23/2011	CN102250073A Method for directly extracting puerarin from fresh kudzuvine pueraria
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011	CN101543491B Application of m-chlorobenzoyl substituted dehydrosilybin for preparing antiviral drugs
11/22/2011	US8063085 Substituted hydantoins
11/17/2011	WO2011143366A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
11/17/2011	WO2011143145A1 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
11/17/2011	WO2011141458A1 Polysubstituted benzofurans and medicinal applications thereof
11/17/2011	US20110281910 Hepatitis C Virus Inhibitors
11/17/2011	US20110281006 Flavor enhancing agent and flavoring composition
11/17/2011	US20110278552 Material for organic electroluminescent device and organic electroluminescent device using same
11/17/2011	US20110278551 Aromatic amine derivative, and organic electroluminescent element
11/17/2011	US20110277378 Process for liquefying a cellulosic material and its products
11/17/2011	CA2799020A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
11/16/2011	EP2069334B1 Aspalathin-like dihydrochalcone, extracts from unfermented rooibos and process for preparation
11/16/2011	CN102245622A Novel aryl C-xyloside compounds, and cosmetic use
11/16/2011	CN102241718A Method for separating and purifying monomer compounds in Stenoloma chusanum(Linn.)Ching
11/16/2011	CN102241657A Synthesis of isoflavone compound through Stille crossed coupling reaction
11/16/2011	CN102241654A Environmentally-friendly synthetic method of pyrimidine compound
11/15/2011	US8058445 Substituted pyridinecarboxamides for the treatment of cancer
11/15/2011	US8058245 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/10/2011	WO2011140334A2 Compounds, methods of making or identifying compounds, and uses thereof
11/10/2011	WO2011140190A1 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	US20110275839 Compounds, intermediates, and methods of preparing the same
11/10/2011	US20110275823 Phenylimidazole compounds
11/10/2011	US20110275633 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
11/10/2011	US20110275625 Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110272681 Light-emitting element material and light-emitting element
11/09/2011	EP2385049A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same
11/09/2011	CN102239157A Diolefin compound, epoxy resin, curable resin composition and cured product
11/09/2011	CN102239147A Quinolone compound and pharmaceutical composition
11/09/2011	CN102234268A Method for preparing ultraviolet (UV)-curable polyisocyanate modified superbranched epoxy acrylate
11/09/2011	CN101648948B Medicine of 3-alkoxyl-mangiferin for lowering blood pressure, synthesis and application
11/08/2011	US8053576 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene
11/08/2011	US8053467 Flavor improving agent, and food and drink containing the same
11/08/2011	US8053436 9-(piperazinylalkyl) carbazoles as bax-modulators
11/08/2011	CA2618393C Bis-aryl amide compounds and methods of use
11/08/2011	CA2493690C Synthetic c-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
11/08/2011	CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/03/2011	WO2011136520A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/03/2011	US20110269956 Hepatitis C Virus Inhibitors
11/03/2011	US20110269753 Heterocyclic compounds as phosphodiesterase inhibitors
11/03/2011	US20110269705 Quinolone compound and pharmaceutical composition
11/02/2011	EP2382207A2 Pi3k/mtor kinase inhibitors
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	CN102229578A Preparation method of 2-arylamino-1,3,4-oxadiazole compound
11/01/2011	CA2479012C Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
10/2011
10/27/2011	WO2011132194A1 Process for the preparation of raloxifene hydrochloride
10/27/2011	WO2011132140A2 Process for the conversion of (2r)-6-fluoro-2-[(2s)-oxiran-2-yl]-3,4-dihydro-2h-chromene to (2r)-6-fluoro-2-[(2r)-oxiran-2-yl]-3,4-dihydro-2h-chromene
10/27/2011	US20110263866 Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process
10/27/2011	US20110263852 Novel process for the preparation of lapatinib and its pharmaceutically acceptable salts
10/27/2011	US20110263696 Proanthocyanidins from cinnamon and its water soluble extract inhibit tau aggregation
10/27/2011	US20110263614 Novel compounds
10/26/2011	EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011	EP2380876A1 1-heterodiene derivative and harmful organism control agent
10/26/2011	EP2379525A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
10/26/2011	EP2379523A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
10/26/2011	EP2379520A2 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
10/26/2011	EP2181985B1 Antiviral Agent
10/25/2011	US8044195 Cross-linked glycopeptide-cephalosporin antibiotics
10/20/2011	WO2011127833A1 Benzoheterocyclic compounds, preparation methods and uses thereof
10/20/2011	US20110257417 Hiv-1 inhibiting pharmaceutical composition containing an ecklonia cava-derived phloroglucinol polymer compound
10/20/2011	US20110257169 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011	US20110256128 Triazole compounds as ksp inhibitors
10/19/2011	EP2377850A1 TRPV1 vanilloid receptor antagonists with a bicyclic portion
10/19/2011	EP2376510A1 Novel aryl c-xyloside compounds, and cosmetic use
10/19/2011	EP2376475A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
10/19/2011	EP2376455A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
10/19/2011	EP2376454A2 Inhibitors of diacylglycerol acyltransferase
10/19/2011	CN102219783A Vilazodone hydrochloride and composition thereof
10/19/2011	CN102219782A Method for extracting and separating viterxin and isovitexin from natural product
10/19/2011	CN102219781A Method for extracting silymarin from milk thistle seed coat
10/18/2011	CA2462345C Dimeric compounds and their use as anti-viral agents
10/13/2011	WO2011125714A1 Germination-stimulant carbamate derivatives and process for preparation thereof
10/13/2011	US20110251289 New compounds for the treatment of cancer
10/13/2011	US20110250454 Preparation of nebivolol
10/13/2011	US20110248217 Electroluminescent device
10/12/2011	EP2373629A1 Compounds for treating cancer
10/12/2011	EP2373313A1 Substituted pyrazole compounds
10/12/2011	CN1934101B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/12/2011	CN102216291A Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
10/12/2011	CN102216268A Novel estrogen receptor ligands
10/12/2011	CN102212563A Biomass gradient vapour-phase cooking pre-treatment method
10/12/2011	CN102212562A Method for pre-treating biomass by coupling vapor phase digestion and flash evaporation
10/11/2011	US8034962 Acid anhydride ester and composition thereof, and heat-curable resin composition and cured product thereof
10/11/2011	US8034928 Fluorescence assays with improved sensitivity
10/11/2011	US8034811 Hydroxamic acid esters and pharmaceutical use thereof
10/06/2011	WO2011121629A1 Indolic derivatives and use thereof in medical field
10/06/2011	WO2011120604A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
10/06/2011	US20110245262 Compounds for treating proliferative disorders
10/05/2011	EP1575940B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer

1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 120